Using genomics to match treatments improved outcomes for certain patients with metastatic breast cancer
The use of multigene sequencing as a therapeutic decision tool improved the outcomes for patients with metastatic breast cancer when the genomic alterations identified were ranked in the I/II tiers of the ESMO Scale for Clinical ...
Dec 8, 2021
0
0